2018 annual financial data
Iovance Biotherapeutics 2018 Operating margin
Iovance Biotherapeutics 2018 operating margin with verified reported values.
Direct answer
Operating margin was Not calculable.
Operating income was -128,258,000 USD and net income was -123,580,000 USD.
Operating cash flow was -101,249,000 USD.
Get free Iovance Biotherapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -128,258,000 USD
- Net income
- -123,580,000 USD
- Operating cash flow
- -101,249,000 USD